No Trump Drug Pricing Plan for J&J—Yet
Johnson & Johnson has not yet secured a drug pricing plan with the White House
Peers like Pfizer and AstraZeneca have made agreements with the Trump administration
J&J's CEO expects to find 'common ground' in discussions regarding the 'most-favored-nation' pricing policy